Angiotech Pharmaceuticals Sells Interventional Products Business
Irell & Manella LLP represented Angiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, in connection with the $362.5 million sale of its interventional products business to Argon Medical Devices, Inc. The transaction closed on April 12, 2013.
The core deal team included Elliot Freier, Sandra Kanengiser and Mitchell Cohen.
Irell & Manella previously represented Angiotech Pharmaceuticals in connection with the sale of its Quill™ knotless tissue closure product line to Ethicon, a subsidiary of Johnson & Johnson, for a purchase price that could reach $62 million.